241 related articles for article (PubMed ID: 2971490)
21. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
Albert D; Bluestein HG; Thompson L; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
[TBL] [Abstract][Full Text] [Related]
22. T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.
Weinberg K; Hershfield MS; Bastian J; Kohn D; Sender L; Parkman R; Lenarsky C
J Clin Invest; 1993 Aug; 92(2):596-602. PubMed ID: 8349799
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
Ullman B; Cohen A; Martin DW
Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
[TBL] [Abstract][Full Text] [Related]
24. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
Mitchell BS; Kelley WN
Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
[TBL] [Abstract][Full Text] [Related]
25. Adenosine deaminase deficiency and immunodeficiencies.
Hirschhorn R
Fed Proc; 1977 Jul; 36(8):2166-70. PubMed ID: 872949
[TBL] [Abstract][Full Text] [Related]
26. Family study on the kindred of an adenosine deaminase deficient child with severe combined immunodeficiency.
Lee CH; Ziegler JB; Rozenberg MC
Aust N Z J Med; 1979 Oct; 9(5):530-3. PubMed ID: 294907
[TBL] [Abstract][Full Text] [Related]
27. [Transplantation of T cell-depleted marrow from parents in a case of severe combined immunodeficiency with adenosine deaminase deficiency].
Yamagami M; Matsuda A; Nakarai T; Katayama K; Saigawa Y; Horita S; Miura M; Kato E; Koizumi S; Taniguchi N
Rinsho Ketsueki; 1987 Sep; 28(9):1669-74. PubMed ID: 3325660
[No Abstract] [Full Text] [Related]
28. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
29. [Immune insufficiency in enzyme defects of purine metabolism].
Müller G
Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
[TBL] [Abstract][Full Text] [Related]
30. Deoxycytidine therapy in two patients with adenosine deaminase deficiency and severe immunodeficiency disease.
Cowan MJ; Wara DW; Ammann AJ
Clin Immunol Immunopathol; 1985 Oct; 37(1):30-6. PubMed ID: 3161676
[TBL] [Abstract][Full Text] [Related]
31. MLC vs CML in a case of T-cell immunodeficiency and ADA deficiency.
Cohen F
Birth Defects Orig Artic Ser; 1975; 11(1):486-8. PubMed ID: 125120
[No Abstract] [Full Text] [Related]
32. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
Carson DA; Kaye J
Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
[TBL] [Abstract][Full Text] [Related]
33. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
Sawami H; Toyokawa Y; Ito K; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
[TBL] [Abstract][Full Text] [Related]
34. [Adenosine deaminase activity and immune dysfunction (author's transl)].
Bremer H; Bauer I; Brock J
Allerg Immunol (Leipz); 1981; 27(1):3-13. PubMed ID: 6455054
[TBL] [Abstract][Full Text] [Related]
35. Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation.
Chen SH; Ochs HD; Scott CR; Giblett ER; Tingle AJ
J Clin Invest; 1978 Dec; 62(6):1386-9. PubMed ID: 372236
[TBL] [Abstract][Full Text] [Related]
36. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
Goday A; Simmonds HA; Webster DR; Morris GS
Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
[TBL] [Abstract][Full Text] [Related]
37. ADA and PNP deficiencies: how it all began.
Giblett ER
Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
[No Abstract] [Full Text] [Related]
38. Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.
Hirschhorn R
Clin Immunol Immunopathol; 1986 Jul; 40(1):157-65. PubMed ID: 3087666
[No Abstract] [Full Text] [Related]
39. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
Bordignon C; Yu SF; Smith CA; Hantzopoulos P; Ungers GE; Keever CA; O'Reilly RJ; Gilboa E
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6748-52. PubMed ID: 2549545
[TBL] [Abstract][Full Text] [Related]
40. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
